Would you discontinue or dose-reduce tamoxifen in a patient who developed hepatic steatosis?  

In the absence of liver enzyme elevation and other risk factors for developing hepatic steatosis (such as obesity and dietary habits), I would be comfortable continuing tamoxifen. However, if tamoxifen-associated hepatic injury is suspected, my preference would be to discontinue tamoxifen or change ...